Gerard Brophy, EVP, Biopharma Production at Avantor, Inc. (AVTR), sold 39,206 shares at $31.27 ($1.2M) on 2022-05-20, disclosed to the SEC on 2022-05-23.
Seasonal sale ($1.2M) by EVP, Biopharma Production — this insider has traded AVTR in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.27 | 19,603 | $613K | 50.0% |
| 2 | $31.27 | 19,603 | $613K | 50.0% |
| Total | $31.27 avg | 39,206 | $1.2M | 100% |
| Filing → |
| AVTR | SELL | 2023-02-02 | $568K | — | Filing → |
| AVTR | SELL | 2022-03-02 | $140K | — | Filing → |
| AVTR | SELL | 2022-02-25 | $207K | — | Filing → |